NexGel shares rise 13.92% intraday after Q3 2025 earnings report highlights progress toward profitability.

NexGel (NXGL) surged 13.92% intraday following the release of its Q3 2025 earnings call highlights, which emphasized progress toward profitability and strategic growth. The company reported a 100.28% increase in net sales for the quarter, driven by expanding partnerships and product innovation in hydrogel technologies. Recent news also highlighted NexGel’s collaboration with STADA AG for North American market expansion and its appointment of a former Shutterstock CFO to its board, signaling operational and market credibility. Additionally, a sustainability-focused article underscored the company’s alignment with industry trends, bolstering investor confidence. These developments collectively reinforced NexGel’s positioning as a leader in advanced healthcare solutions, directly supporting the sharp intraday rally.